These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29550091)

  • 1. Optical Coherence Tomographic Image Pattern of Metallic Bioresorbable Vascular Scaffold Restenosis.
    Roa-Garrido J; Cardenal-Piris RM; El Amrawy AM; Gomez-Menchero A; Camacho Freire S; Diaz-Fernandez JF
    JACC Cardiovasc Interv; 2018 Apr; 11(7):707-708. PubMed ID: 29550091
    [No Abstract]   [Full Text] [Related]  

  • 2. Very late scaffold thrombosis: insights from optical coherence tomography and histopathology.
    Joner M; Nicol P; Rai H; Richter H; Foin N; Ng J; Cuesta J; Rivero F; Serrano R; Alfonso F
    EuroIntervention; 2018 Apr; 13(18):e2169-e2173. PubMed ID: 29155382
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation.
    Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
    Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
    Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
    Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
    Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
    Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Latib A; Colombo A
    JACC Cardiovasc Imaging; 2015 May; 8(5):617-618. PubMed ID: 25457765
    [No Abstract]   [Full Text] [Related]  

  • 8. Restenosis in a Collapsed Magnesium Bioresorbable Scaffold.
    Barkholt TØ; Neghabat O; Terkelsen CJ; Christiansen EH; Holm NR
    Circ Cardiovasc Interv; 2017 Oct; 10(10):. PubMed ID: 29042399
    [No Abstract]   [Full Text] [Related]  

  • 9. Magmaris very late in-scaffold restenosis: Has the "black boxes" nightmare come back?
    Bayón J; Santás-Álvarez M; Ocaranza-Sánchez R; González-Juanatey C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E174-E176. PubMed ID: 31763757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold.
    McCutcheon K; Bennett J; Marynissen T; Adriaenssens T
    Acta Cardiol; 2020 Feb; 75(1):85-86. PubMed ID: 30735472
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioresorbable Scaffold Failure Due to Chronic Recoil in a Myocardial Bridge.
    Giavarini A; Longo G; Chen J; Rodríguez R; Di Mario C
    JACC Cardiovasc Interv; 2016 Mar; 9(6):e49-51. PubMed ID: 26803423
    [No Abstract]   [Full Text] [Related]  

  • 12. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
    Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
    [No Abstract]   [Full Text] [Related]  

  • 13. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
    Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
    EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
    [No Abstract]   [Full Text] [Related]  

  • 14. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.
    Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605
    [No Abstract]   [Full Text] [Related]  

  • 16. Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography.
    Balanescu DV; Donisan T; Dayah T; Palaskas N; Lopez-Mattei J; Kim P; Pinnix CC; Moudgil R; Balanescu SM; Herrmann J; Cilingiroglu M; Marmagkiolis K; Iliescu C
    Int J Cardiovasc Imaging; 2019 May; 35(5):759-760. PubMed ID: 30758691
    [No Abstract]   [Full Text] [Related]  

  • 17. Early Collapse of a Magnesium Bioresorbable Scaffold.
    Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085
    [No Abstract]   [Full Text] [Related]  

  • 18. First in human: imaging guided bioresorbable magnesium scaffolds in acute myocardial infarction.
    Alfonso F; García-Guimaraes M; Bastante T; González-Bartol E; Cuesta J; Rivero F
    Coron Artery Dis; 2018 Aug; 29(5):441-443. PubMed ID: 29537986
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioresorbable stent restenosis: new devices, novel situations.
    Núñez-Gil IJ; Echavarría M; Escaned J; Biagioni C; Feltes G; Fernández-Ortiz A
    J Invasive Cardiol; 2014 Dec; 26(12):E164-6. PubMed ID: 25480999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold: The FANTOM II Study.
    Abizaid A; Carrié D; Frey N; Lutz M; Weber-Albers J; Dudek D; Chevalier B; Weng SC; Costa RA; Anderson J; Stone GW;
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1832-1838. PubMed ID: 28935075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.